Air Barrier System for the Reduction of Airborne Colony-forming Units During Total Shoulder Arthroplasty

NCT ID: NCT03782675

Last Updated: 2018-12-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-02-28

Study Completion Date

2019-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to determine whether the Air Barrier System device reduces airborne colony-forming units (e.g., bacteria) present at a surgery site during total shoulder arthroplasty surgeries.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Air Barrier System (ABS) is a device that uses localized clean air flow to shield a surgery site from ambient airborne contamination. This study examines the hypothesis that the ABS can reduce the presence of airborne CFU and particles at the surgery site during total arthroplasty surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteo Arthritis Shoulders

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Total shoulder replacement operating room air surgical site infection airborne CFU

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

In the control arm, the ABS device will be placed as usual on the patient, but the airflow will NOT be activated. Only the technician in the room will be aware whether the device the device is turned on or not.

Group Type SHAM_COMPARATOR

Control

Intervention Type DEVICE

The Air Barrier System will be deployed onto the surgical field, but the airflow will not be activated, so this is a sham control comparator.

Air Barrier System

In the experimental (interventional) arm, the ABS device will be placed as usual on the patient, and the airflow will be activated. Only the technician in the room will be aware whether the device is turned on or not.

Group Type EXPERIMENTAL

Air Barrier System

Intervention Type DEVICE

The Air Barrier System is a device that uses localized clean air flow to shield a surgery site from ambient airborne microorganisms that are shed into the air from people present in the operating room.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Control

The Air Barrier System will be deployed onto the surgical field, but the airflow will not be activated, so this is a sham control comparator.

Intervention Type DEVICE

Air Barrier System

The Air Barrier System is a device that uses localized clean air flow to shield a surgery site from ambient airborne microorganisms that are shed into the air from people present in the operating room.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Candidate for total shoulder arthroplasty

Exclusion Criteria

* Prior history of infection
* Revision surgery
* Screens positive for MRSA
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Texas Orthopedic Hospital

UNKNOWN

Sponsor Role collaborator

Nimbic Systems, LLC

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gregory Stocks, MD

Role: PRINCIPAL_INVESTIGATOR

Texas Orthopedic Hospital

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Gregory Stocks, MD

Role: CONTACT

Phone: 713-799-8600

Email: [email protected]

Sean Self

Role: CONTACT

Phone: 284-565-5715

Email: [email protected]

References

Explore related publications, articles, or registry entries linked to this study.

Stocks GW, Self SD, Thompson B, Adame XA, O'Connor DP. Predicting bacterial populations based on airborne particulates: a study performed in nonlaminar flow operating rooms during joint arthroplasty surgery. Am J Infect Control. 2010 Apr;38(3):199-204. doi: 10.1016/j.ajic.2009.07.006. Epub 2009 Nov 12.

Reference Type BACKGROUND
PMID: 19913327 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ABS-104

Identifier Type: -

Identifier Source: org_study_id